7.5 mg tirzepatide Zepbound mg/0.5 mL injection (single-dose pen) Images How many units is 7.5

Frequently Asked Questions Not yet

Available from: Ahmadi H, Fotesko K, Ba-Ali S, Hamann S, Kolko M

Consistent Commitment: Consistency is the key to unlocking optimal results

These include: Persistent fatigue, cold intolerance, or constipation (suggesting hypothyroidism) Excessive thirst, increased urination, or blurred vision (indicating poor glycaemic control) Abdominal pain, nausea, or vomiting (potential pancreatitis, a rare but serious adverse effect) Right upper quadrant pain, jaundice, pale stools, or dark urine (possible gallbladder disease, which has increased risk with GLP-1 receptor agonists) [1] [2] New visual symptoms including floaters or blurred vision (potential diabetic retinopathy complications) Mood changes, particularly low mood or increased anxiety New or worsening oedema in the legs, ankles, or face Lack of expected weight loss after three to six months at therapeutic doses should also prompt discussion with your healthcare provider

Patients with Type 2 diabetes are prescribed Tirzepatide to improve their glycemic control